SCHEMBL20535150

SCHEMBL20535150

CC(CC(=O)O)c1cccc(Cl)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.58
HPGD P15428 1/20 0.58
FFAR1 O14842 3/20 0.52
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
ACP3 P15309 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
CTSA P10619 1/20 0.45
ADRB2 P07550 1/20 0.44
ADRB1 P08588 1/20 0.44
ADRB3 P13945 1/20 0.44
OGT O15294 1/20 0.44
GPR139 Q6DWJ6 1/20 0.44
TRPM8 Q7Z2W7 1/20 0.44
ATM Q13315 1/20 0.44
CACNA1G O43497 1/20 0.44
CACNA2D1 P54289 1/20 0.44
CACNA1B Q00975 1/20 0.44
CACNB1 Q02641 1/20 0.44
CACNA1C Q13936 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15076015 0.84 MEN1 (0.69) ALDH1A1HPGDMEN1KMT2AACP3
SCHEMBL15076017 0.84 MEN1 (0.69) ALDH1A1HPGDMEN1KMT2AACP3
SCHEMBL15076019 0.84 MEN1 (0.69) ALDH1A1HPGDMEN1KMT2AACP3
SCHEMBL4990705 0.84 ALDH1A1 (0.47) ALDH1A1HPGDFFAR1MEN1KMT2A
SCHEMBL27909941 0.83 ALDH1A1 (0.49) ALDH1A1HPGDMEN1KMT2AACP3
SCHEMBL1913816 0.82 CACNA2D1 (0.47) ALDH1A1HPGDFFAR1MEN1KMT2A
SCHEMBL30514317 0.82 CACNA2D1 (0.47) ALDH1A1HPGDFFAR1MEN1KMT2A
SCHEMBL14691472 0.82 MEN1 (0.54) ALDH1A1HPGDFFAR1MEN1KMT2A
SCHEMBL3188356 0.81 MEN1 (0.53) MEN1KMT2AACP3CTSAADRB2
SCHEMBL3658103 0.81 HIF1A (0.50) ALDH1A1HPGDFFAR1ADRB2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609869-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF Bayer Aktiengesellschaft (DE) 2020-02-19 EP disclosed
WO-2018189011-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2018-10-18 WO disclosed